Search Results
FOCUS4-N: Maintenance capecitabine monotherapy in mCRC
Learnings from the FOCUS4 trial
2021 ASCO Direct Philadelphia | Colorectal Cancer Summary | Dr. Arturo Loaiza Bonilla
FOCUS4: A flagship clinical trial
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC
#ESMO21 Expert Video Report on colorectal cancer
Future developments in CRC
Next Step - Adjuvant Therapy - Chemo Pill - Xeloda | Our Journey
Colorectal cancer trial updates at ASCO 2021
Tesetaxel Plus Reduced Dose Capecitabine for HR+ Metastatic Breast Cancer
☕ Transitioning to Chemo Pills 💊 (Capecitabine, Oral Chemotherapy 😋)
Rectal Cancer- 1st day of Xeloda Chemo pills Vlog
